ARCHIVES

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

Fox Chase Symposium Tro Focus On Year 2000 Goals

August 21, 1987

In Brief: David Cole Named President of The Medical University of South Carolina

May 9, 2014